Chang-Cheng Zheng (Changcheng Zheng)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Acute Myeloid Leukemia

Peritoneal Dialysis

Newly Diagnosed

Prognostic Factors

Top Venues

Medicina (Kaunas, Lithuania)

Blood and lymphatic cancer : targets and therapy

Cancer management and research

Journal of blood medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dan Liu, Juan Tong, Erling Chen, Li Wang, Lei Xue, Xuhan Zhang, Na Zhao, Xing Hu, Chang-Cheng Zheng
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood and lymphatic cancer : targets and therapy 14 (2024)
Dan Liu, Juan Tong, Erling Chen, Li Wang, Lei Xue, Xuhan Zhang, Na Zhao, Xing Hu, Chang-Cheng Zheng
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF. Blood and lymphatic cancer : targets and therapy 14 (2024)
Xiaoyu Wang, Yingqiao Zhu, Dan Liu, Lijun Zhu, Juan Tong, Chang-Cheng Zheng
Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study. Journal of blood medicine 15 (2024)
Xiaoyu Wang, Yingqiao Zhu, Dan Liu, Lijun Zhu, Juan Tong, Chang-Cheng Zheng
Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study. Journal of blood medicine 15 (2024)
Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Chang-Cheng Zheng
The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Chang-Cheng Zheng
The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Chang-Cheng Zheng
The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Chang-Cheng Zheng
The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Jiqian Jiang, Yan Wang, Dan Liu, Xiaoyu Wang, Yingqiao Zhu, Juan Tong, Erling Chen, Lei Xue, Na Zhao, Tingting Liang, Chang-Cheng Zheng
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes. ImmunoTargets and therapy 12 (2023)
Li Wang, Na Zhao, Li Zhou, Juan Tong, Lei Xue, Lei Zhang, Yongsheng Han, Xingbing Wang, Liangquan Geng, Baolin Tang, Huilan Liu, Weibo Zhu, Xiaoyan Cai, Xin Liu, Xiaoyu Zhu, Zimin Sun, Chang-Cheng Zheng
Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study. Clinical interventions in aging 17 (2022)
Xinhui Zhang, Shanglong Feng, Jin Xu, Na Zhao, Xing Hu, Li Zhou, Juan Tong, Lei Xue, Lei Zhang, Yongsheng Han, Xingbing Wang, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Huilan Liu, Weibo Zhu, Xiaoyan Cai, Xin Liu, Zimin Sun, Chang-Cheng Zheng
All-trans retinoic acid 45 mg/m2 is superior to 25 mg/m2 as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting. Blood cancer journal 11 (1) (2021)
Xiuxiu Lin, Anhui Xu, Li Zhou, Na Zhao, Xinhui Zhang, Jin Xu, Shanglong Feng, Chang-Cheng Zheng
Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia. International journal of general medicine 14 (2021)
Jin Xu, Xinhui Zhang, Shanglong Feng, Na Zhao, Xin Hu, Yaxin Cheng, Yue Wu, Li Zhou, Juan Tong, Chang-Cheng Zheng
Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting. The Journal of international medical research 49 (4) (2021)
Li Zhou, Xinhui Zhang, Shanglong Feng, Na Zhao, Xing Hu, Liangliang Huang, Chang-Cheng Zheng
Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma. OncoTargets and therapy 13 (2020)
Yong Wang, Ben-Jie Shan, Xia-Bo Shen, Chang-Cheng Zheng, Jin-Quan Wang, Gui-Ling Li, Yue-Yin Pan
Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer. Cancer management and research 12 (2020)
Shanglong Feng, Li Zhou, Xinhui Zhang, Baolin Tang, Xiaoyu Zhu, Huilan Liu, Zimin Sun, Chang-Cheng Zheng
Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 109/L. Cancer management and research 11 (2019)